Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Macrophages orchestrate antiviral defense and epithelial repair in a human iPSC-derived alveolar air-liquid interface
Declan L. Turner, Hannah Baric, Katelyn Patatsos, Sahel Amoozadeh, Michael See, Kathleen A. Strumila, Jack T. Murphy, Jeremy J. Wiyana, Liam Gubbels, Elizabeth S. Ng, Andrew G. Elefanty, Melanie R. Neeland, Shivanthan Shanthikumar, Sarah L. Londrigan, Mirana Ramialison, Fernando J. Rossello, Ed G. Stanley, Rhiannon B. Werder
Declan L. Turner, Hannah Baric, Katelyn Patatsos, Sahel Amoozadeh, Michael See, Kathleen A. Strumila, Jack T. Murphy, Jeremy J. Wiyana, Liam Gubbels, Elizabeth S. Ng, Andrew G. Elefanty, Melanie R. Neeland, Shivanthan Shanthikumar, Sarah L. Londrigan, Mirana Ramialison, Fernando J. Rossello, Ed G. Stanley, Rhiannon B. Werder
View: Text | PDF
Research Article Cell biology Infectious disease Inflammation

Macrophages orchestrate antiviral defense and epithelial repair in a human iPSC-derived alveolar air-liquid interface

  • Text
  • PDF
Abstract

The lung alveoli are continually exposed to inhaled pathogens and environmental hazards and rely on coordinated communication between alveolar macrophages and type 2 alveolar epithelial cells (AT2s) to maintain homeostasis. Disruption of these interactions can impair immunity and repair, contributing to acute and chronic respiratory diseases. To better define these mechanisms and support therapeutic discovery, we established a human iPSC-derived air-liquid interface platform that captures key features of AT2-macrophage crosstalk. Using this system, we show that coculture enhances AT2-specific transcriptional programs including lipid synthesis, while macrophages actively phagocytose AT2-derived surfactant. iPSC-derived macrophages adopt an alveolar macrophage–like phenotype and respond to AT2-derived M-CSF. During respiratory infection, macrophages play a crucial role in modulating epithelial inflammatory responses, augmenting antiviral immunity, and limiting viral replication. We further identify a role for macrophages in epithelial repair, where VEGF-mediated signaling to macrophages increases epithelial permeability during viral infection. Together, these findings reveal dimensions of AT2-macrophage cooperation in homeostasis, infection, and repair, and demonstrate how this iPSC-derived platform can be used to dissect mechanisms that may initiate or drive the progression of respiratory diseases.

Authors

Declan L. Turner, Hannah Baric, Katelyn Patatsos, Sahel Amoozadeh, Michael See, Kathleen A. Strumila, Jack T. Murphy, Jeremy J. Wiyana, Liam Gubbels, Elizabeth S. Ng, Andrew G. Elefanty, Melanie R. Neeland, Shivanthan Shanthikumar, Sarah L. Londrigan, Mirana Ramialison, Fernando J. Rossello, Ed G. Stanley, Rhiannon B. Werder

×

Figure 1

Establishment of iPSC-derived AT2 and macrophage air liquid interface cocultures.

Options: View larger image (or click on image) Download as PowerPoint
Establishment of iPSC-derived AT2 and macrophage air liquid interface co...
(A) Schematic representation of the coculture system. Separate iAT2 and iMac differentiations were performed. iAT2s were matured at air-liquid interface (ALI) for 3–7 days, then iMacs added to the apical compartment. (B) Prior to coculture, iAT2s expressed surfactant protein C, SFTPC-tdTomato, and NKX2-1-GFP. iMacs express CD68, CD14, and CD11b. Scale bar: 50 μm. (C) Live cell confocal imaging of iAT2 (red, marked by SFTPC-tdTomato) and iMacs (blue, stained with CellTrace violet) in coculture at ALI (48 hours after addition of iMacs). Scale bar: 100 μm. (D) Confocal imaging of iAT2s (red, SFTPC-tdTomato) and iMacs (green, CD68); scale bar: 10 μm, nuclei (blue) (13 days after addition of iMacs). (E) Percentage marker retention of iAT2s and iMacs after 21 days of coculture. iAT2s maintained expression of SFTPC-tdTomato and NKX2-1-GFP; iMacs expressed CD45 and CD14. (F) MFI of SFTPC-tdTomato in iAT2 alone or iAT2s after 7 days of iMac coculture. (G) Transepithelial electrical resistance (TEER) in iAT2 alone or iAT2s cocultured with iMacs for 7 days. (H) MFI of CD86 after 7 days cultured in CK-DCI, CK-DCI + M-CSF, or cocultured with iAT2s in CK-DCI. n = 3 experimental replicates of independent wells of a differentiation; data shown as mean ± SD. Statistical significance was determined by unpaired, 2-tailed Student’s t test (2 groups) or 1-way ANOVA (>2 groups); **P < 0.005, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts